Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion

Journal of Experimental Medicine

Volumn 190, Issue 8, 1999, Pages 1103-1113

  Raftery, Martin J ^a   Behrens, Christian K ^b   Müller, Anke ^a   Krammer, Peter H ^b   Walczak, Henning ^b   Schönrich, Günther ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Activation induced cell death; Antigen presentation; Apoptosis; Herpes simplex virus; Viral immune evasion

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL DEATH; CYTOTOXIC T LYMPHOCYTE; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REINFECTION; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENES, MHC CLASS I; HERPESVIRUS 1, HUMAN; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032702025     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.8.1103     Document Type: Article

References (60)

1. Roizman, B., and A.E. Sears. 1996. Herpes simplex viruses and their replication. In Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. Lippincott-Raven Publishers, Philadelphia. 2231-2295.
2. Whitley, R.J. 1996. Herpes simplex viruses. In Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. Lippincott-Raven Publishers, Philadelphia. 2297-2342.
3. Ward, P.L., and B. Roizman. 1998. Evasion and obstruction: the central strategy of the interaction of human herpesviruses with host defense. In Herpesviruses and Immunity. P.G. Medveczky, H. Friedman, and M. Bendinelli, editors. Plenum Press, New York. 1-32.
4. Rouse, B.T., and S.S. Atherton. 1998. Immunopathology of herpesvirus infection. In Herpesviruses and Immunity. P.G. Medveczky, H. Friedman, and M. Bendinelli, editors. Plenum Press, New York. 33-51.
5. + T cell subset distribution in lymph nodes draining the site of herpes simplex virus infection. Eur. J. Immunol. 27:2310-2316.
6. Nahmias, A.J., S. Kibrick, and R.C. Rosan. 1964. Viral leukocyte interrelationships. I. Multiplication of DNA virus -herpes simplex - in human leukocyte cultures. J. Immunol. 93:69-74.
7. Kirchner, H., C. Kleinicke, and H. Northoff. 1977. Replication of herpes simplex virus in human peripheral T lymphocytes. J. Gen. Virol. 37:647-649.
8. Montgomery, R.I., M.S. Warner, B.J. Lum, and P.G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell. 87: 427-436.
9. Mauri, D.N., R. Ebner, R.I. Montgomery, K.D. Kochel, T.C. Cheung, G.-L. Yu, S. Ruben, M. Murphy, R.J. Eisenberg, G.H. Cohen, et al. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator. Immunity. 8:21-30.
10. Galvan, V., and B. Roizman. 1998. Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc. Natl. Acad. Sci. USA. 95: 3931-3936.
11. Leopardi, R., C. van Sand, and B. Roizman. 1997. The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc. Natl. Acad. Sci. USA. 94:7891-7896.
12. Koyama, A.H., and Y. Miwa. 1997. Suppression of apoptotic DNA-fragmentation in herpes simplex virus type 1-infected cells J. Virol. 71:2567-2571.
13. + T lymphocytes. Cell. 77:525-535.
14. Hill, A., B. Barnett, A. McMichael, and D. McGeoch. 1994. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus type 1 and type 2. J. Immunol. 152:2736-2741.
15. Jerome, K.R., J.F. Tait, D.M. Koelle, and L. Corey. 1998. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J. Virol. 72: 436-441.
16. Blakely, A., K. Gorman, H. Ostergaard, K. Svoboda, C.-C. Liu, J.D.-E. Young, and W.R. Clark. 1987. Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity. J. Exp. Med. 166:1070-1083.
17. Verret, C.R., A.A. Firmenich, D.M. Kranz, and H.N. Eisen. 1987. Resistance of cytotoxic T lymphocytes to the lytic effects of their toxic granules. J. Exp. Med. 166:1536-1547.
18. Skinner, M., and J. Marbrook. 1987. The most efficient cytotoxic T lymphocytes are the least susceptible to lysis. J. Immunol. 139:985-987.
19. + cytotoxic T lymphocytes is due to fratricide. J. Immunol. 151:658-667.
20. Müller, C., and J. Tschopp. 1994. Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perform. J. Immunol. 153:2470-2478.
21. Müller, A., L. Schmitt, M. Raftery, and G. Schönrich. 1998. Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechanism of local tolerance induction. Eur. J. Immunol. 28:3488-3498.
22. Azuma, M., M. Cayabyab, D. Buck, J.H. Phillips, and L.L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogeneic proliferative response and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:353-360.
23. + T cell response. J. Exp. Med. 187:341-348.
24. Schönrich, G., U. Kalinke, F. Momburg, M. Malissen, A.-M. Schmitt-Verhulst, B. Malissen, G.J. Hämmerling, and B. Arnold. 1991. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell. 65:293-304.
25. Albert, F., M. Buferne, C. Boyer, and A.-M. Schmitt-Verhulst. 1982. Interaction between MHC-encoded-products and cloned T cells. I. Fine specificity of induction of proliferation and lysis. Immunogenetics. 76:533-549.
26. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:31-37.
27. Otten, G., and W.M. Yokoyama. 1992. Flow cytometry analysis using the Becton Dickinson FACScan. In Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. Greene Publishing and Wiley-Interscience, New York. 5.4.1-5.4.19.
28. b-specific cytotoxic T cell clone detect several clone-specific molecules. J. Immunol. 136:1937-1944.
29. Wunderlich, J., G. Shearer, and A. Livingstone. 1997. Induction and measurement of cytotoxic T lymphocyte activity. In Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. John Wiley & Sons, Inc., New York. 3.11.1-3.11.20.
30. Matzinger, P. 1991. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods. 145:185-192.
31. Possavad, C.M., J.J. Newton, and K.L. Rosenthal. 1994. Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus. J. Virol. 68:4072-4074.
32. Klas, C., K.-M. Debatin, R.R. Jonker, and P.H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625-630.
33. Shresta, S., C.T.N. Pham, D.A. Thomas, T.A. Graubert, and T.J. Ley. 1998. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10:581-587.
34. McLeod, J.D., L.S.K. Walker, Y.I. Patel, G. Boulougouris, and D.M. Samson. 1998. Activation of human T cells with superantigen (staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95. J. Immunol. 160:2072-2079.
35. Ahn, K., T.H. Meyer, S. Uebel, P. Sempé, H. Djaballah, Y. Yang, P.A. Peterson, K. Früh, and R. Tampé. 1996. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47. EMBO (Eur. Mol. Biol. Organ.) J. 15:3247-3255.
36. Tomazin, R., A.B. Hill, P. Jugovic, I. York, P. van Endert, H. Ploegh, D.W. Andrews, and D.C. Johnson. 1996. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO (Eur. Mol. Biol. Organ.) J. 15:3256-3266.
37. Li, J., D. Rosen, D. Ronen, C.K. Behrens, P.H. Krammer, W.R. Clark, and G. Berke. 1998. The regulation of CD95L expression and function in CTL. J. Immunol. 161:3943-3949.
38. Bossi, G., and G.M. Griffiths. 1999. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 5:90-96.
39. Van Parijs, L., and A.K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 280:243-248.
40. + cells to bacterial superantigens. Eur. J. Immunol. 22:1935-1938.
41. Hornung, F., L.X. Zheng, and M.J. Lenardo. 1997. Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. J. Immunol. 159:3816-3822.
42. Combadière, B., C. Reis e Sousa, C. Trageser, L.-X. Zheng, C.R. Kim, and M.J. Lenardo. 1998. Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo. Immunity. 9:305-313.
43. Dhein, J., H. Walczak, C. Baeumler, K.M. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373:438-441.
44. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, et al. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation induced apoptosis in T-cell hybridomas. Nature. 373:441-444.
45. Ju, S.-T., D.J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:444-448.
46. Van Parijs, L., A. Ibraghimov, and A.K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 4:321-328.
47. Alnemri, E.S., D.J. Livingston, D.W. Nicholson, G. Salvesen, N.A. Thornberry, W.W. Wong, and J. Yuan. 1996. Human ICE/CED-3 protease nomenclature. Cell. 87:171.
48. Peter, M.E., F.C. Kischkel, C.G. Scheuerpflug, J.P. Medema, K.-M. Debatin, and P.H. Krammer. 1997. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/ caspase 8) to the CD95 death inducing signaling complex. Eur. J. Immunol. 27:1207-1212.
49. Hu, S., C. Vincenz, M. Buller, and V.M. Dixit. 1997. A novel family of viral death effector domain-containing molecules that inhibit both CD95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272:9621-9624.
50. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J.L. Bodmer, M. Schroter, et al. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 386:517-521.
51. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.L. Bodme, M. Schroeter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature. 388:190-195.
52. Goltsev, Y.V., A.V. Kovalenko, E. Arnold, E.E. Varvolomeev, V.M. Brodianskii, and D. Wallach. 1997. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272:19641-19644.
53. Hu, S., C. Vincenz, J. Ni, R. Gentz, and V.M. Dixit. 1997. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD95-induced apoptosis. J. Biol. Chem. 272:17255-17257.
54. Srinivasula, S.M., M. Ahmad, S. Ottilie, F. Bullrich, S. Banks, Y. Wang, T. Fernandes Alnemri, C.M. Croce, G. Litwack, K.J. Tomaselli, et al. 1997. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/ TNFR1-induced apoptosis J. Biol. Chem. 272:18542-18545.
55. Westendorp, M.O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K.M. Debatin, and P.H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 375:497-500.
56. Debatin, K.M., A. Fahrig-Faissner, S. Enenkel-Stoodt, W. Kreuz, A. Benner, and P.H. Krammer. 1994. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood. 83:3101-3103.
57. Katsikis, P.D., E.S. Wunderlich, C.A. Smith, L.A. Herzenberg, and L.A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181: 2029-2036.
58. McCloskey, T.W., N. Oyaizu, M. Kaplan, and S. Pahwa. 1995. Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry, 22:111-114.
59. Badley, A.D., D.H. Dockrell, A. Algeciras, S. Ziesmer, A. Landay, M.M. Lederman, E. Connick, H. Kessler, D. Kuritzkes, D.H. Lynch, et al. 1998. In vivo analysis of Fas/FasL interactions in HIV-infected patients. J. Clin. Invest. 102:79-87.
60. Xu, X.-N., B. Laffert, G.R. Screaton, M. Kraft, D. Wolf, W. Kolanus, J. Mongkolsapay, A.J. McMichael, and A.S. Baur. 1999. Induction of Fas ligand expression by HIV involves the interaction of nef with the T cell receptor ζ chain. J. Exp. Med. 189:1489-1496.